MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

NCT03928470 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 379

Last updated 2019-12-24

No results posted yet for this study

Summary

To Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Conditions

  • Non-erosive Reflux Disease(NERD)

Interventions

DRUG

EsoDuo Tab. 20/800mg

Nexium Tab. 20mg

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Oh Young Lee, M.D., Ph.D. · Hanyang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-29
Primary Completion
2019-12-20
Completion
2019-12-20

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03928470 on ClinicalTrials.gov